Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 09 Jan 2024 for Acadia Pharmaceuticals INC. Read the official filing
Filing timeline
BuySaleAustin D. Kim
Insider track record
Disclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Austin D. Kim: trading record in brief
This profile gathers the share dealings of Austin D. Kim in Acadia Pharmaceuticals Inc. In total, 11 filings cover trades dated from 6 January 2022 to 8 January 2024.
No open-market purchase appears, only 3 sales worth €43k. Other entries cover 8 option exercises. So far in 2024, the count stands at no purchases and 1 sale.
The newest entry dates from 9 January 2024: an open-market sale of €16k, in Acadia Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Austin D. Kim
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
1,634 sharesCommon StockSEC:0001209191-24-001267:0
590 shares@ US$29.9637.3% of flowCommon StockSEC:0001209191-24-001267:1
36,174 sharesCommon StockSEC:0001209191-23-052390:0
917 shares@ US$21.1840.9% of flowCommon StockSEC:0001209191-23-026746:1
3,005 sharesCommon StockSEC:0001209191-23-026746:0
4,773 sharesCommon StockSEC:0001209191-23-023861:0
1,633 sharesCommon StockSEC:0001209191-23-002894:0
589 shares@ US$17.130321.9% of flowCommon StockSEC:0001209191-23-002894:1
3,005 sharesCommon StockSEC:0001209191-22-026938:0
2,213 shares0Common StockSEC:0001209191-22-013277:0
1,633 sharesCommon StockSEC:0001209191-22-002750:0
11 of 11 declarations
